A Three-dimensional Collagen Lattice Induces Protein Kinase C-ζ Activity: Role in α2 Integrin and Collagenase mRNA Expression by Xu, Jiahua & Clark, Richard A.F.
 
ã
 
 The Rockefeller University Press, 0021-9525/97/01/473/11 $2.00
The Journal of Cell Biology, Volume 136, Number 2, January 27, 1997 473–483 473
 
A Three-dimensional Collagen Lattice
 
Induces Protein Kinase C-
 
z
 
 
 
Activity: Role
 
in
 
 
 
a
 
2
 
 Integrin and Collagenase mRNA Expression
 
Jiahua Xu and Richard A.F. Clark
 
Department of Dermatology, School of Medicine, SUNY at Stony Brook, Stony Brook, New York 11794-8165
 
Abstract. 
 
A three-dimensional collagen lattice can pro-
vide skin fibroblasts with a cell culture environment 
that simulates normal dermis. Such a collagen matrix 
environment regulates interstitial collagenase (type I 
metalloproteinase [MMP-1], collagenase-1) and col-
lagen receptor 
 
a
 
2
 
 subunit mRNA expression in both 
unstimulated or platelet-derived growth factor–stimu-
lated dermal fibroblasts (Xu, J., and R.A.F. Clark. 
1996. 
 
J. Cell Biol.
 
 132:239–249). Here we report that the 
collagen gel can signal protein kinase C (PKC)-
 
z
 
 activa-
tion in human dermal fibroblasts. An in vitro kinase as-
say demonstrated that autophosphorylation of PKC-
 
z
 
 
immunoprecipitates was markedly increased by a col-
lagen matrix. In contrast, no alteration in PKC-
 
z
 
 pro-
tein levels or intracellular location was observed. DNA 
binding activity of nuclear factor 
 
k
 
B (NF-
 
k
 
B), a down-
stream regulatory target of PKC-
 
z
 
, was also increased 
by fibroblasts grown in collagen gel. The composition 
of the NF-
 
k
 
B/Rel complexes that contained p50, was 
not changed. The potential role of PKC-
 
z
 
 in collagen 
gel–induced mRNA expression of collagen receptor 
 
a
 
2
 
 
subunit and human fibroblast MMP-1 was assessed by 
the following evidence. Increased levels of 
 
a
 
2
 
 and 
MMP-1 mRNA in collagen gel–stimulated fibroblasts 
were abrogated by bisindolylmaleimide GF 109203X 
and calphostin C, chemical inhibitors for PKC, but re-
tained when cells were depleted of 12-myristate 13-ace-
tate (PMA)–inducible PKC isoforms by 24 h of pre-
treatment with phorbol PMA. Antisense oligonucleotides 
complementary to the 5
 
9
 
 end of PKC-
 
z
 
 mRNA se-
quences significantly reduced the collagen lattice–stim-
ulated 
 
a
 
2
 
 and MMP-1 mRNA levels. Taken together, 
these data indicate that PKC-
 
z
 
, a PKC isoform not in-
ducible by PMA or diacylglycerol, is a component of 
collagen matrix stimulatory pathway for 
 
a
 
2
 
 and MMP-1 
mRNA expression. Thus, a three-dimensional collagen 
lattice maintains the dermal fibroblast phenotype, in 
part, through the activation of PKC-
 
z
 
.
 
T
 
he
 
 interactions of cells with extracellular matrix
(ECM)
 
1
 
 are essential for cell behavior such as mor-
phology, growth, motility, differentiation, and gene
expression. In many biological and pathophysiological
processes such as embryonic development, wound healing,
tumor invasion and metastasis, and fibrosis, ECM plays
this important role not only by its different components
but also by its tightly regulated spatial and temporal orga-
nizations (Hay, 1991; Lin and Bissell, 1993; Grinnell, 1994;
Clark, 1996). Three-dimensional ECM culture systems
have been developed to simulate natural interactions be-
tween cells and ECM more closely than the traditional in
vitro monolayer culture (Grinnell, 1994; Clark et al., 1995;
Ronnov-Jessen et al., 1995; Streuli et al., 1995; Sankar et al.,
1996). Among those systems, a relaxed collagen lattice
populated by fibroblasts is considered an in vitro system
representative of a normal fibrous stroma in vivo such as
the dermis (Grinnell, 1994). When fibroblasts are embed-
ded in the lattice consisting mainly of type I collagen, they
contract the initially loose network to a dense tissue-like
structure. This process is accompanied by a fundamental
reprogramming of fibroblast morphology and metabolism.
This results in down-regulation of type I collagen synthesis
(Eckes et al., 1993), attenuation of cellular response to
growth factors (Lin and Grinnell, 1993; Clark et al., 1995),
induction of collagenase (Unemori and Werb, 1986) and
the collagen receptor 
 
a
 
2
 
 integrin subunit (Klein et al., 1991),
and modulation of platelet-derived growth factor (PDGF)
effects on integrin receptor expression (Xu and Clark,
1996).
Much attention has been paid to the role of protein ki-
nase C (PKC) in ECM-regulated cellular activities. A fam-
ily of serine/threonine-specific protein kinases, PKC has
been linked to cell proliferation, differentiation, and regu-
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maleimide GF 109203X; CalC, calphostin C; CAM, cell adhesion mole-
cule; CHX, cycloheximide; COL, collagen gel; DAG, diacylglycerol;
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N
 
-[1-(2,3-dioleoyloxy)propyl]-
 
N
 
,
 
N
 
,
 
N
 
-trimethylammonium chlo-
ride; ECM, extracellular matrix; MMP-1, type I metalloproteinase; NF-
 
k
 
B,
nuclear factor 
 
k
 
B; PC-PLC, phosphatidylcholine-hydrolyzing phospholi-
pase C; PDGF, platelet-derived growth factor; PKC, protein kinase C;
PMA, phorbol 12-myristate 13-acetate; TC, tissue culture plates; TNF, tu-
mor necrosis factor.
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lation of gene expression. This enzyme family can be di-
vided into three groups (for review see Nishizuka, 1995).
The classic group containing isoforms 
 
a
 
, 
 
b
 
I, 
 
b
 
II, and 
 
g
 
 de-
pends on Ca
 
2
 
1
 
 and phorbol ester/diacylglycerol (DAG)
for activity. The novel group containing isoforms 
 
d
 
, 
 
e
 
, 
 
h
 
, 
 
u
 
,
and 
 
m
 
 is phorbol ester/DAG-dependent but does not re-
quire Ca
 
2
 
1
 
. An atypical group containing PKC-
 
l
 
, 
 
t
 
, and 
 
z
 
is not activated by phorbol ester/DAG. Cell adhesion has
been reported to signal PKC activation. For example, ad-
hesion of HeLa cells to a collagen substratum induces
PKC activity (Chun and Jacobson, 1992, 1993). During
HeLa cell adhesion to a gelatin substratum, PKC-
 
e
 
 is
translocated from cytosolic to membrane fractions (Chun
and Jacobson, 1996). Integrin cell adhesion molecules
could be direct substrates for activated PKC since PKC
phosphorylates the cytoplasmic domain of 
 
a
 
6A integrin
subunit in vitro (Gimond et al., 1995). The PKC activity
has been shown to be required for the spreading of several
cell types, such as macrophage on immunoglobulin-coated
surfaces (Li et al., 1996), Hela cells on a collagen substra-
tum (Chun and Jacobson, 1992, 1993), and CHO cells on
fibronectin (Vuori and Ruoslahti, 1993). PKC is also in-
volved in the formation of focal contacts by human
embryo fibroblasts on substrata composed of fibronectin
since its inhibitors reduced focal adhesion and stress fiber
formation (Woods and Couchman, 1992).
The physiological activators of atypical PKC isoforms are
not known. Evidence in the past few years has suggested
that products of phosphoinositol 3-kinase, phosphoinositol
3,4-bisphosphate, and phosphoinositol 3,4,5-trisphosphate
can induce PKC-
 
z
 
 autophosphorylation activity in a cell-
free assay (Nakanishi et al., 1993). Also, transducers of tu-
mor necrosis factor (TNF)-
 
a
 
,
 
 
 
such as ceramide, the product
of sphingomyelin hydrolysis by acidic sphingomyelinase,
and arachidonic acid (AA), a product of cellular phospho-
lipase A2, can activate PKC-
 
z
 
 (Nakanishi and Exton, 1992;
Muller et al., 1995). The increased PKC-
 
z
 
 activity by sphin-
gomyelinase has also been observed (Lozano et al., 1994).
In addition, PKC-
 
z
 
 is directly associated with Ras (Diaz-
Meco et al., 1994
 
b
 
).
The regulatory role of PKC-
 
z
 
 in collagen-mediated cel-
lular process has not been addressed. Nevertheless, studies
have shown that cell adhesion to collagen substratum in-
creases AA release (Chun and Jacobson, 1992; Auer and
Jacobson, 1995) and Ras activity (Kapron-Bras et al.,
1993), suggesting potential correlations between collagen
signaling processes and PKC-
 
z
 
 activation. The aim of this
study is to understand how a three-dimensional collagen
gel sends biochemical signals to induce cellular expression
of a collagen receptor integrin subunit, 
 
a
 
2
 
, and collagenase
type I metalloproteinase (MMP-1). In this report, we dem-
onstrate that the collagen lattices activate fibroblast PKC-
 
z
 
.
The PKC-
 
z
 
 activity appears to be a component of the nu-
clear signaling cascade that leads to integrin 
 
a
 
2
 
 and MMP-1
expression.
 
Materials and Methods
 
Cell Culture
 
Human fibroblast cultures established by outgrowth from healthy human
skin biopsies were kindly provided by Marcia Simon (Department of Der-
matology, SUNY at Stony Brook). The cells were maintained in DME
(GIBCO BRL, Gaithersburg, MD), supplemented with 10% FCS (Hy-
clone Labs, Logan, UT), 100 U/ml penicillin, 100 U/ml streptomycin
(GIBCO BRL) and grown in a humidified atmosphere of 5% CO
 
2
 
 and
95% air at 37
 
8
 
C. Cells between population doubling levels 15 and 20 (the
6th and 10th passage) were used for the experiments.
 
Antibodies and Inhibitors
 
Cycloheximide (CHX) was obtained from Sigma Chemical Co. (St. Louis,
MO). Bisindolylmaleimide GF 109203X (BIM) was purchased from Cal-
biochem-Novabiochem Corp. (La Jolla, CA). Calphostin C and cheleryth-
rine were purchased from LC Laboratories (Woburn, MA). Polyclonal
antibodies against human protein kinase C-
 
z
 
 were purchased from
GIBCO BRL. Monoclonal antibodies against human protein kinase C-
 
t
 
,
-
 
l
 
 and -
 
a
 
 were purchased from Transduction Laboratories (Lexington,
KY). Polyclonal antibodies against PKC-
 
m
 
, nuclear factor 
 
k
 
B (NF-
 
k
 
B),
p65, and p50 were purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Polyclonal antibodies against human PDGF AB and cyclin A were
purchased from Upstate Biotechnology (Lake Placid, NY).
 
Preparation of Collagen Lattices
 
Collagen gels were prepared according to a procedure previously de-
scribed (Xu and Clark, 1996). Pepsin-solubilized bovine dermal collagen
dissolved in 0.012 M HCl was 99.9% pure containing 95–98% type I col-
lagen and 2–5% type III collagen (Vitrogen 100; Cetrix Laboratories, Palo
Alto, CA). Collagen for cultures was prepared by mixing 2.0 mg/ml of type I
collagen, 100 U/ml penicillin, 100 U/ml streptomycin, and 1% FCS in DME
at pH 7.0–7.4. Human dermal fibroblasts from subconfluent cultures
starved in 1% FBS for 24 h were mixed with 10 ml collagen solution for a
final concentration of 5 
 
3
 
 10
 
5
 
 cells/ml. The collagen cell suspension (4 ml)
was immediately placed onto 2% BSA (Kankakee, IL)–coated 60-mm
petri dishes (Falcon; Becton-Dickinson Labware, Lincoln Park, NJ) and
incubated at 37
 
8
 
C for 2 h (or for the time periods described in figure leg-
ends) before the addition of 5 ml of 1% FCS/DME to each dish.
After incubation at 37
 
8
 
C in 95% air, 5% CO
 
2
 
, and 100% humidity for
the indicated time, cultures were carefully washed twice in DME and pro-
cessed for various analyses. In experiments where inhibitors were used,
the levels of lactate dehydrogenase activity released were measured (LD
Diagnostic kit, Sigma Chemical Co.) and found to be similar to cells cul-
tured in the absence of inhibitors.
 
Coating of Petri Dishes
 
For monolayer collagen coating of plastic dishes, the collagen used for lat-
tices was diluted to a final concentration of 50 
 
m
 
g/ml with PBS. This solu-
tion was added to plastic dishes at a final concentration of 6.4 
 
m
 
g/cm
 
2
 
 and
incubated overnight at 4
 
8
 
C. Coated dishes were blocked with 2% BSA for
2 h at room temperature and rinsed with PBS twice before use.
 
Incubation with Antibodies
 
Collagen gels minus fibroblasts and 1% FCS/DME were preincubated
with polyclonal antibodies against PDGF AB (100 
 
m
 
g/ml) and, as a con-
trol, cyclin A (100 
 
m
 
g/ml) for 1 h at 4
 
8
 
C. Fibroblasts starved in 1% FCS/
DME for 1 d were detached by trypsinization and then seeded into col-
lagen gels containing relevant antibodies. For antibody blocking of PDGF
stimulation, the medium was replaced with fresh medium containing 30
ng/ml PDGF-BB preincubated with or without anti-PDGF for 1 h.
(PDGF-BB  was generously provided by Charles Hart of ZymoGenetics, Se-
attle, WA.) All the control media were replaced accordingly, minus
PDGF-BB. Cells were further incubated for 18 h.
 
Northern Analysis of Total Cellular RNA
 
Total RNA was isolated from cell monolayers and collagen gel cultures
using a modification of guanidinium thiocyanate method (Chromczynski
and Sacchi, 1987). After centrifugation at 14,000 
 
g
 
 to remove culture me-
dium, collagen gels were dissolved in 4 M guanidinium isothiocyanate and
repeatedly passed through a 20 1/2-gauge needle. For Northern blot hy-
bridization, 3–5 
 
m
 
g of total RNA was treated with glyoxal/DMSO, sep-
arated by electrophoresis on an 1% agarose gel in 10 mM phosphate
buffer, pH 7.0, and transferred to Hybond
 
1
 
 nylon membranes (Amer-
sham Corp., Arlington Heights, IL). Ethidium bromide (0.5 
 
m
 
g/ml) was in-
cluded in the gel to monitor equal loading by the quantity of 18 S and 28 S 
Xu and Clark 
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ribosomal RNA present. cDNA probes were labeled with [
 
a
 
-
 
32
 
P]dCTP by
the random primer procedure (Du Pont/NEN, Boston, MA). Oligonucle-
otide probes were end-labeled with [
 
g
 
-
 
32
 
P]ATP (Du Pont/NEN) and in
the presence of polynucleotide kinase (Boehringer Mannheim Corp.,
Indianapolis, IN). The filters were hybridized to the labeled probes in
QuickHyb solution (Stratagene, La Jolla, CA) for 3 h at 68
 
8
 
C and washed
according to manufacturer’s protocol. The signals were detected by auto-
radiography (model X-Omat AR; Kodak Eastman, Rochester, NY) at
 
2
 
80
 
8
 
C for optimal exposure. All results shown are representative of at
least two independent experiments. Human 
 
a
 
2
 
 cDNA was a generous gift
from Dr. Yoshikazu Takada (Scripps Institute, La Jolla, CA) (Takada and
Hemler, 1989). Human MMP-1 cDNA was purchased from American
Type Culture Collection (Rockville, MD). Human 
 
a
 
5
 
 cDNA was pur-
chased from GIBCO BRL. An oligonucleotide complementary to 28 S ri-
bosomal RNA was purchased from Clontech (Palo Alto, CA).
 
Preparation of Cell Extracts
 
Fibroblasts grown in collagen gels were released by digestion of gels with
collagenase D (Boehringer Mannheim Corp.). Cells grown on plastic
plates were scraped and subsequently processed as those released from
collagen gel. Cells from all culture conditions were then washed with ice-
cold PBS twice and resuspended in lysis buffer (50 mM Tris, pH 7.5, 150
mM NaCl, 1% Triton X-100, 2 mM EDTA, 1 mM EGTA, and proteinase
inhibitors). After incubation on ice for 30 min, cells were repeatedly
passed through a 26 1/2-gauge needle followed by centrifugation at 14,000 
 
g
 
for 20 min. Protein content was determined using a bicinchonic acid assay
(Pierce, Rockford, IL).
 
Isolation of Nuclei
 
The nuclei were prepared according to a protocol previously described
with some modifications (Greenberg and Ziff, 1984). Cells released from
collagen gel or scraped from plastic plates were washed twice with ice-cold
PBS. Cells were precipitated by centrifugation at 500 
 
g
 
 for 5 min at 4
 
8
 
C.
Cell pellet was washed in buffer A once (10 mM Tris, pH 7.4, 3 mM CaCl
 
2
 
, 2
mM MgCl
 
2
 
), resuspended in 1 ml lysis buffer B (0.5% NP-40 in buffer A)
and homogenized in a Dounce homogenizer with a “B” pestle. After ex-
amination under a microscope to monitor the release of nuclei, the homog-
enate was centrifuged at 500 
 
g
 
 at 4
 
8
 
C. The pellet was designated as nuclei,
whereas the supernatant was designated as cytoplasmic fraction. The nu-
clear pellet was stored in buffer C (50 mM Tris, pH 8.0, 40% glycerol, 5
mM MgCl
 
2
 
, 0.1 mM EDTA, 0.5 mM PMSF, 1 
 
m
 
M leupeptin). The protein
content in cytoplasm and nuclei was determined using the bicinchonic acid
assay (Pierce).
 
Western Immunoblotting
 
Proteins from cell and nuclear extracts were separated on 8% SDS–poly-
acrylmide gel and transferred to polyvinyl difluoride membranes (Mili-
pore Corp., Bedford, MA). Samples containing 4–7 
 
m
 
g of total proteins
were loaded onto the gel. The membranes were incubated with a blocking
solution containing 2% BSA, 2% horse serum, 50 mM Tris, pH 7.5, 150
mM NaCl, and 0.05% Tween 20 for 1 h at room temperature and then in-
cubated overnight at 48C with various antibodies: monoclonal PKC-a, -t,
-l and b-tubulin, and polyclonal PKC-z and -m. After incubation with
horseradish peroxidase–conjugated goat anti–rabbit antibody (1:1,000 di-
lution; Amersham Corp.) in 50 mM Tris, pH 7.5, 150 mM NaCl, and
0.05% Tween 20 for 1 h at room temperature, the blots were then visual-
ized with enhanced chemiluminescence (Amersham Corp.).
Immunoprecipitation and In Vitro PKC-z
Activity Assay
Cell extracts prepared from 106 cells were incubated at 48C overnight with a
rabbit polyclonal antibody against human PKC-z used in Western analysis.
The immune complexes were recovered by anti–rabbit IgG agarose beads
(Sigma Chemical Co.). The resulting immunoprecipitates were washed
three times with a cold buffer containing 20 mM Tris, pH 7.5, 0.5 mM
EDTA, 0.5 mM EGTA, 25 mg/ml leupeptin, and 25 mg/ml aprotinin be-
fore they were mixed in a final volume of 50 ml assay solution (35 mM
Tris, pH 7.5, 15 mM MgCl2, 1 mM MnCl2, 0.5 mM EGTA, 0.1 mM CaCl2,
1 mM sodium orthovanadate, and 100 mM [g-32P]ATP with or without 280
mg/ml phosphatidylserine) and incubated at 308C for 10 min. After reac-
tions were stopped by the addition of the equal volume of 23 gel loading
buffer, the samples were boiled for 3 min and precipitated. The superna-
tant was analyzed by SDS-PAGE followed by autoradiography.
Gel Mobility Shift Assay
Nuclear extracts were prepared by a modified miniextraction protocol
(Schreiber et al., 1989). Cells were washed with ice-cold PBS twice and hy-
potonic buffer A once (10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl2,
0.5 mM PMSF, 0.5 mM DTT). Cells were lysed by incubation in lysis
buffer (0.2% NP-40 in buffer A) for 10 min on ice. After centrifugation at
500 g for 4 min at 48C, the nuclear pellet was resuspended in extraction
buffer C (20 mM Tris, pH 7.9, 25% glycerol, 1.5 mM MgCl2, 0.2 mM
EDTA, 20 mM KCl, 0.5 mM PMSF, 0.5 mM DTT) and D (20 mM Tris,
pH 7.9, 25% glycerol, 1.5 mM MgCl2, 0.2 mM EDTA, 1.2 M KCl, 0.5 mM
PMSF, 0.5 mM DTT) at a 1:2 ratio followed by incubation on ice for 20
min. The supernatant was collected as nuclear extracts after centrifugation
at 14,000 g for 8 min. The nuclear protein was determined using the bicin-
chonic acid assay (Pierce).
Gel mobility shift assay was performed with nuclear extracts prepared
as described above. NF-kB and Sp-1 enhancer element consensus se-
quences 59-AGT TGA GGG GAC TTT CCC AGG C-39 and 59-ATT
CGA TCG GGG CGG GGC GAG C-39, respectively, were purchased
(Promega Corp., Madison, WI). These oligonucleotides were labeled by
[g-32P]ATP. The nuclear extracts (3–5 mg) were incubated with 1 mg poly
(dI/dC) (Boehringer Mannheim Corp.) and 2 mg BSA (GIBCO BRL) in a
binding buffer (10 mM Tris, pH 7.9, 5 mM MgCl2, 50 mM KCl, 10% glyc-
erol, and 1–5 3 104 cpm end-labeled oligonucleotides) for 20 min at room
temperature. The samples were separated on a 5% native polyacrylamide
gel in 0.53 TBE buffer (Tris-borate-EDTA). For supershift assays, the re-
action mixture minus the probe was incubated with 32P-labeled oligonu-
cleotides for 20 min followed by incubation with 2 ml antibodies for 30 min
at room temperature. The samples were separated on a 4% native poly-
acrylamide gel.
Down-Regulation of PKC-z Protein by Antisense 
Inhibition of Translation
The procedure was essentially as previously described (Xu et al., 1996)
with modifications to accommodate the collagen gel culture. Phospho-
rothioate DNA oligonucleotides with the sequences 59-ATGCCCAG-
CAGGACC-39 (sense 1143), 59-GGTCCTYGCTGGGCAT-39 (antisense
1142), and 59-GGTCCTGCTGGGCATGCG AAAGC-39 (antisense 1144)
were synthesized by Promega. Subconfluent adult human dermal fibro-
blasts were treated with oligonucleotides in DME containing 20 mg/ml li-
pofectin (N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chlo-
ride [DOTMA]; GIBCO BRL) for 6–8 h at 378C in the presence of 5%
CO2. After this time, the medium containing lipofectin was replaced by
fresh medium containing appropriate oligonucleotides. After 48 h, cells
were subcultured into collagen gel containing freshly added oligonucleo-
tides. After incubation for 18 h, total RNA or cell extracts were prepared
and analyzed with Northern blotting, Western blotting, or immunoprecip-
itation and kinase assay.
Results
Inhibition of Collagen Gel–induced a2 and MMP-1 
mRNA Levels
Previous studies have shown that collagen gel increases a2
integrin mRNA steady-state levels in human foreskin
(Klein et al., 1991) and adult dermal (Xu and Clark, 1996)
fibroblasts. Relaxed collagen gels also induce fibroblast col-
lagenase (Unemori and Werb, 1986; Langholz et al., 1995).
Here we demonstrate that the induction of a2 and MMP-1
mRNA occurred only when cells were cultured in a three-
dimensional collagen gel, not on collagen monolayer–
coated surface (Fig. 1 A), in agreement with Langholz et al.
(1995). A time course showed that the mRNAs appeared
as early as 4 h after cells were placed in collagen lattices
(Fig. 1 B). a2 mRNA reached the maximum after 24 h,
whereas MMP-1 continued to increase up to 72 h (Fig. 1 B).The Journal of Cell Biology, Volume 136, 1997 476
Since PDGF-BB also induces steady-state levels of a2
mRNA (Ahlen and Rubin, 1994; Xu et al., 1996), we asked
whether the induction by collagen gel was caused by
PDGF present in collagen preparations. Antibody against
PDGF has been shown to neutralize PDGF biological ef-
fects (Ferns, 1991). Polyclonal antibody against PDGF AB
was therefore included in the collagen gel cultures and, as
control, in fibroblasts grown on conventional tissue culture
plates (TC) and in collagen gel (COL) before PDGF stim-
ulation. As shown in Fig. 1 C, the antibodies did not affect
the induction by COL (lanes 1 and 2) but drastically inhib-
ited PDGF effects (lanes 3 and 4). The possibility that the
failure of anti-PDGF to inhibit COL induction may result
from PDGF-BB in collagen gel higher than 30 ng/ml, a
concentration used for PDGF effects on TC, was exam-
ined. Since the saturating concentration of PDGF-BB to in-
duce a2 expression is between 10–15 ng/ml (Xu and Clark,
1996), we rationalized that if high concentration of PDGF
in COL was responsible for a2 induction, the addition of
PDGF cannot further increase a2 expression. Fibroblasts
grown in collagen gel were further stimulated by PDGF-BB
at 30 ng/ml, and integrin a2 mRNA level was greatly in-
creased compared to COL or PDGF alone (Fig. 1 C, lanes
5 and 9), confirming our previous observation (Xu and
Clark, 1996). This further induction was inhibited by anti-
PDGF in a dose-dependent manner (Fig. 1 C, lanes 10 and
11). A control antibody, cyclin A, did not have any effect
(Fig. 1 C, lane 12). Taken together, signals from three-
dimensional collagen lattices responsible for induction of
integrin a2 and MMP-1 do not emanate from PDGF con-
tamination.
The requirement of newly synthesized proteins and
posttranslational modifications was investigated next. Pro-
tein synthesis was required since both types of mRNA di-
minished in the presence of CHX, a protein synthesis in-
hibitor (Fig. 2 A). To understand what role PKC might play,
three specific PKC inhibitors, BIM, calphostin C (CalC),
and chelerythrine, were used in the study. Both BIM and
CalC blocked the induction of both mRNAs in a dose-
dependent manner, indicating that protein phosphoryla-
tion by PKC is required for both a2 and MMP-1 mRNA
Figure 1. Northern analysis of integrin a2 subunit and MMP-1
mRNA induced by three-dimensional collagen lattices. Normal
human dermal fibroblasts were starved 1 d in 1% FCS/DME be-
fore subculture in test conditions. (A) Cells were subcultured on
tissue culture plates (TC), collagen monolayer coated surface (ML),
and in three-dimensional collagen lattices (COL). (B) Cells were
subcultured on tissue culture plates (TC) and in three-dimen-
sional lattices (COL) for the time indicated. (C) Collagen gel mix
was preincubated with anti-PDGF at 100 ng/ml (lanes 2 and 6)
and at indicated concentrations (lanes 10 and 11), and with anti-
cyclin A at 100 ng/ml (lane 12). Cells in collagen gel (lanes 5, 6,
and 10–12) or on TC (lanes 3, 4, and 8) were stimulated with 30
ng/ml PDGF-BB preincubated with (lanes 4, 6, 10, and 11) or
without anti-PDGF (lanes 3, 5, 8, and 9) or with anti-cyclin A
(lane 12) 4 h after subculture. Total RNA was probed with hu-
man a2 integrin or MMP-1 cDNAs as indicated. Equal loading
was monitored by UV light examination of ethidium bromide–
stained gel and confirmed by hybridization of the same blot with
[32P]labeled probe for 28 S ribosomal RNA. Results are represen-
tative of two experiments.
Figure 2. Inhibition of collagen gel induction of a2 and MMP-1
mRNA levels. (A and B) Cells were preincubated with inhibitors
before subculture. (A) 10 mg/ml cycloheximide (CHX), a protein
synthesis inhibitor, for 15 min. (B) PKC inhibitors bisindolylma-
leimide GF 109203X (BIM) and calphostin C (CalC) at concen-
trations indicated for 1 h and 30 min, respectively. The incubation
with inhibitors was continued for 18 h after subculture. (C) Qui-
escent cells either untreated or incubated for 24 h with PMA (300
ng/ml) were subcultured in collagen lattices or stimulated with
PMA (50 ng/ml) for 16 h. Total RNA was probed with human a2
integrin and MMP-1 cDNAs. Equal loading was monitored by
UV light examination of ethidium bromide–stained gel and con-
firmed by hybridization of the same blot with [32P]labeled probe
for 28S ribosomal RNA. Results are representative of two inde-
pendent experiments. T, tissue culture plates; C, collagen lattices.Xu and Clark Integrin and Protease Regulation by Extracellular Matrix 477
expression (Fig. 2 B). Chelerythrine, however, did not
demonstrate the inhibitory effect on the induction (data
not shown).
Since there are 12 PKC isoforms identified so far, nine
of which are phorbol 12-myristate 13-acetate (PMA)/DAG-
inducible, whereas three were not induced by PMA, the
identity of the PKC isoform(s) that mediated collagen-
induced  a2 and MMP-1 mRNA expression was sought. As
a first step, we investigated whether this PKC was PMA-
inducible or not. A widely used strategy is to deplete cellu-
lar PMA-inducible PKC levels by treating cell culture
chronically with PMA (Larrodera et al., 1990). This ap-
proach depletes PKC isoforms sensitive to PMA/DAG ac-
tivation. Thus, quiescent human fibroblast cultures were
exposed to PMA (300 ng/ml) for 24 h before they were
subcultured into collagen gel. PMA induction of cells cul-
tured on tissue culture plates were performed in parallel as
a control. a2 and MMP-1 mRNA steady-state levels were
then determined. As expected, PMA was unable to induce
either  a2 or MMP-1 mRNA in cells chronically treated
with PMA (Fig. 2 C, right lane). In contrast, collagen gel
promoted a potent response in a2 mRNA expression in
PMA-pretreated cells, which was only slightly lower than
that in untreated cells (Fig. 2 C, middle two lanes). This re-
sult indicates the involvement of atypical PKC(s). How-
ever, MMP-1 mRNA response to collagen gel was reduced
from 10-fold to 6.3-fold increase in cells chronically treated
with PMA (Fig. 2 C, middle two lanes). These results sug-
gest that collagen lattices activate an atypical PKC isoform
that, to a different extent, is required for a2 and MMP-1
mRNA expression.
The Expression of Atypical PKC Isoforms
To determine which atypical PKC may be required for the
collagen gel induction, protein levels of atypical PKC iso-
forms in human dermal fibroblasts were first examined.
We performed Western analysis of total cell extracts after
cells were grown in collagen gels for various time periods.
In these experiments, HeLa cell extracts were used as a
positive control (data not shown), as they contain all of the
PKC isoforms examined (Chun and Jacobson, 1996). All
three known members of the atypical PKC subfamily, z, t,
and l, were detected in human dermal fibroblasts (Fig. 3).
The antibody against the PKC-z isoform detected a high
level of immunoreactive proteins from the lysates. Col-
lagen gel did not change its amount. PKC-l and -t were
detected at relatively low levels in both monolayer and
collagen gel cultures, and no obvious differences could be
discerned in the levels from the two culture conditions
(Fig. 3). When lysate amount, antibody concentration, or
exposure time was increased, the results became question-
able because of the high background. A novel PKC iso-
form, PKC-m, was also examined. Western blot detected
PKC-m at a level comparable with PKC-z. In contrast to
atypical PKC isoforms that were not synthetically affected
by the collagen gel culturing, the cellular protein level of
PKC-m decreased as cells were incubated in collagen gel
for 18 h (Fig. 3). These results demonstrate that collagen
lattices, which were capable of altering some PKC isoform
protein levels, did not change the protein amount of atypi-
cal PKCs in human fibroblasts.
Collagen Gel Induction of PKC-z Kinase Activity
Since collagen gel induction of a2 integrin and MMP-1
mRNA involved atypical PKC isoforms, collagen lattices
may induce atypical PKC enzyme activity. The kinase ac-
tivity of PKC-z was investigated for the following reasons.
PKC-z is CalC (Larivee et al., 1994) and BIM sensitive
(Xu et al., 1996), chelerythrine insensitive (Thompson and
Fields, 1996), and not down-regulated by PMA (Wooten,
1994), which is consistent with the results observed thus
far (Fig. 2, B and C). Furthermore, PKC-z was the only
member of atypical PKC subfamily detected in human fi-
broblasts in significant amounts (Fig. 3). To assess whether
collagen gel can induce PKC-z kinase activity, fibroblasts
grown in collagen gel for various time periods were as-
sayed for PKC-z kinase activity. PKC-z present in the cell
extracts was immunoprecipitated with a polyclonal anti-
body. PKC-z was autophosphorylated by kinase activities
associated with the immunoprecipitates. The kinase activ-
ity was induced 30 min after fibroblasts cultured in col-
lagen gel (4.6-fold), reached the maximum at 4 h (9.2-
fold), and decreased after 4 h (Fig. 4, A and C). Cells
grown on tissue culture plates, however, remained unstim-
ulated during the entire time course (data not shown). The
presence of phosphatidylserine, a PKC activator, increased
Figure 3. Western analysis of PKC isoforms in total cell lysates.
Normal human dermal fibroblasts were cultured 1 d in 1% FCS/
DME before subculture in test conditions. Cells were subcultured
on tissue culture plates (TC) or in three-dimensional collagen lat-
tices (COL) for the time indicated. Total cellular proteins were
extracted, quantified with BCA assay, blotted, and detected with
antibodies against PKC-z, -t, -l, and -m.The Journal of Cell Biology, Volume 136, 1997 478
the PKC-z activity impressively from unstimulated (seven-
fold) and slightly from stimulated cells (11.5-fold, a 20%
increase). Therefore, collagen gel appears to be an activa-
tor for fibroblast PKC-z, as determined by kinase activity
associated with PKC-z immunoprecipitates.
Collagen Gel Induction of DNA Binding Activity of 
Transcription Factor NF-kB
PKC-z has been reported as a positive regulator of the ac-
tivity of a transcription factor, NF-kB (Diaz-Meco et al.,
1993). Cells that display enhanced PKC-z phosphorylation
activity also increase NF-kB DNA binding activity in re-
sponse to sphingomyelinase (Lozano et al., 1994), ras p21
(Diaz-Meco et al., 1993), and TNF-a (Muller et al., 1995).
The induction of PKC-z activity by cells incubated in col-
lagen gels prompted us to ask whether NF-kB DNA bind-
ing activity was also induced. Nuclear extracts were pre-
pared from human fibroblasts grown in collagen gel from
30 min to 24 h. The NF-kB DNA binding activity present
in the nuclear extracts was detected by gel mobility shift
assay using a DNA probe encompassing the kB motif (see
Materials and Methods). As seen in Fig. 4 B, a 30-min in-
cubation of human fibroblasts in collagen gel induced the
formation of specific kB DNA–protein complexes. The
NF-kB DNA binding activity remained similar from 30 min
to 4 h (Fig. 4 C, 2.9–3.8-fold increases) but increased mod-
estly after 24 h of incubation in collagen gel (Fig. 4 C, 4.9-
fold increases). The quantification of the NF-kB DNA
binding activity revealed a kinetic pattern in concord with,
if not identical to, that of PKC-z kinase activity (Fig. 4 C).
Cells grown on tissue culture plates, on the contrary, did
not demonstrate any change in the NF-kB DNA binding
activity (data not shown). Competition experiments with
an unlabeled kB consensus sequence confirmed the speci-
ficity of the binding complexes. As a control, the binding
activity to the Sp1, a transcription factor, consensus se-
quence was also examined (Fig. 4 B). The Sp1 DNA bind-
ing activity present in nuclear extracts was not altered by
cells cultured in collagen gel. Therefore, we conclude that
this three-dimensional cell culture system increased PKC-z
activity in association with the activation of NF-kB DNA
binding complexes. The composition of the NF-kB DNA
binding complexes was examined next. The supershift as-
say showed that p50 of NF-kB/Rel family proteins was one
component of the binding complex (Fig. 4 D, II) regard-
less of culture condition. Antibody to p65, however, only
shifted a very low amount of the binding complex (Fig.
4 D, I), suggesting that the binding complex may be com-
posed of other member(s) of NF-kB/Rel family. There-
fore, collagen gel induced the p50-containing complex bind-
ing to NF-kB site without changing protein composition.
Antisense Translational Inhibition of PKC-z
The results presented so far have suggested that collagen
gel was an activator of PKC-z activity and that collagen
gel–induced a2 and MMP-1 mRNA expression required
atypical PKC isoform activity. The potential role of PKC-z
in collagen gel–induced a2 and MMP-1 mRNA expression
was then investigated. To establish a direct connection be-
tween these two events, we used a previously described
strategy to remove PKC-z protein through translation in-
hibition by antisense oligonucleotides (Xu et al., 1996). Anti-
sense phosphorothioate oligonucleotides 1142 and 1144
have sequences targeted at the begining of the open read-
ing frame of PKC-z cDNA (Barbee et al., 1993). This GC-
rich site is in a nonconserved variable region (V1) of PKC
family (Nishizuka, 1992), which differs significantly among
Figure 4. Stimulation of PKC-z and NF-kB DNA binding activity
by three-dimensional collagen lattices. Normal human dermal fi-
broblasts were cultured 1 d in 1% FCS/DME before subculture in
test conditions. Cells were subcultured on tissue culture plates
(TC) or in three-dimensional collagen lattices (COL) for the
times indicated. (A) PKC-z kinase activity assay. Total cellular
proteins were extracted, quantified with BCA assay, and immu-
noprecipitated with a polyclonal antibody against PKC-z in the
presence or absence of a synthetic peptide to which the antibody
was raised (Peptide). The immunoprecipitates were incubated in
a kinase assay buffer for 10 min at 308C. Unless specified, the re-
actions were carried out in the absence of phosphatidylserine.
The kinase activity was determined by autophosphorylation as
described in Materials and Methods. The results are representa-
tive of three independent experiments. (B) Gel mobility shift as-
say. Nuclear extracts were prepared and assayed for DNA bind-
ing activity of NF-kB and SP1 by gel mobility shift as described in
Materials and Methods. Arrows indicate specific bindings. The
results are representive of three independent experiments. (C)
Quantification of A and B. (D) Supershift assay. Nuclear extracts
prepared from cells stimulated with collagen gel (COL) for 24 h
and on tissue culture plates (TC) were incubated with labeled
NF-kB consensus sequences before futher incubation with anti-
bodies against p65 and p50. I, the supershift caused by p65; II, the
supershift caused by p50; III, the specific NF-kB binding.Xu and Clark Integrin and Protease Regulation by Extracellular Matrix 479
PKC isoforms. Antisense oligonucleotides 1142 and 1144
are essentially the same except that 1144 was designed to
have an additional looping secondary structure at its 39
end to reduce the possible degradation caused by 39 exo-
nuclease (Tang et al., 1993). Previously we have found that
the antisense oligonucleotides at concentrations higher
than 2.5 mM can inhibit human fibroblast PKC-z protein
level by at least 70% (Xu et al., 1996). Therefore, fibro-
blasts were lipid-transfected with antisense oligonucle-
otides 1142 or 1144 at 2.5 mM. As a control, some cells
were transfected with “sense” oligonucleotide 1143. The
transfected cells were then subcultured into collagen gels
and further treated with oligonucleotides for 18 h. The de-
pletion of PKC-z protein levels by antisense inhibition of
translation was monitored by Western blotting (Fig. 5 A)
and kinase activity of PKC-z immunoprecipitates (Fig. 5 B).
The results from Fig. 5 demonstrated a significant reduc-
tion of PKC-z protein and its associated kinase activity af-
ter treatment with both oligonucleotides, 1142 and 1144.
The specificity of antisense inhibition was confirmed by
probing the membrane with an mAb against PKC-a. The
equal loading was confirmed by detection with an mAb
against b-tubulin (Fig. 5 A).
Such cells were harvested for analysis of a2 and MMP-1
mRNA expression. Antisense treatment inhibited colla-
gen gel induction of a2 expression up to 60% (Fig. 6). Both
oligonucleotides 1142 and 1144 had similar effects. These
results are consistent with observations of cells treated
with the PKC inhibitors, BIM and CalC (Fig. 2 B), and
chronically with PMA (Fig. 2 C). MMP-1 expression was
also inhibited by antisense treatment, although less effec-
tively with 1142 and more with 1144. The expression of a
fibronectin receptor integrin subunit, a5, was not affected
by either a collagen gel environment or antisense treat-
Figure 5. Specific down-regulation of protein levels and PKC-z
activity by antisense inhibition of translation. Subconfluent nor-
mal dermal human fibroblasts were either untreated or treated
with sense (1143) or antisense oligonucleotides (1142 and 1144)
at 2.5 mM in DME containing 20 mg/ml DOTMA for 6–8 h. After
this time, the medium containing DOTMA was replaced by fresh
medium containing appropriate oligonucleotides. Cells were sub-
cultured 48 h later on tissue culture plates (TC) or in three-
dimensional collagen lattices (COL) and continuously incubated
in appropriate oligonucleotides for 18 h. Total cellular proteins
were extracted, quantified with BCA assay, and assayed for
PKC-z in vitro kinase activity or protein level. (A) Western blot
detection of PKC-z, PKC-a, and b-tubulin. (B) In vitro kinase ac-
tivity in immunoprecipitates of PKC-z.
Figure 6. Antisense-mediated down-regulation of PKC-z protein
inhibits collagen gel induction of integrin a2 and MMP-1 mRNA
expression. Total cellular RNA was extracted from normal human
dermal fibroblasts after incubation in the presence or absence of
sense (1143) or antisense (1142 and 1144) oligonucleotides com-
plementary to the 59-end of the PKC-z transcript at 2.5 mM. Be-
fore RNA harvest, cultures were incubated in collagen lattices for
18–24 h. Total RNA was probed with human a2 integrin, MMP-1
and a5 integrin cDNAs. Equal loading was monitored by UV light
examination of ethidium bromide–stained gel and confirmed by
hybridization of the same blot with [32P]labeled probe for 28S ri-
bosomal RNA. Results are representative of two independent ex-
periments.The Journal of Cell Biology, Volume 136, 1997 480
ment, confirming the specificity of the antisense inhibition.
Therefore, PKC-z is involved in collagen gel induction of
the a2 integrin subunit and MMP-1 mRNA expression.
The Cytoplasmic and Nuclear Localization of PKC-z
Several PKC isoforms have been reported to be present in
the nucleus, including PKC-d and PKC-e (Ventura et al.,
1995). The nuclear localization of those PKC isoforms
seems directly correlated to its functional role in regulat-
ing cellular biosynthetic activities. For example, the phor-
bol ester–regulated expression of opioid peptide gene in
rat myocardial cells was reported as a possible target of nu-
clear PKC-d and -e through autocrine or paracrine mecha-
nisms (Ventura et al., 1995). The involvement of PKC-z in
mRNA expression of a2 and MMP-1 prompted us to ask
whether PKC-z is a cytosolic or nuclear protein in human
dermal fibroblasts. Previously, PKC-z has been reported
present in cytoplasm and nucleus in species such as rat and
rabbit (Masmoudi et al., 1989; Hagiwara et al., 1990; Disat-
nik et al., 1994; Rosenberger et al., 1995). To assess this
possibility of human PKC-z, the distribution of PKC-z as
well as -m in cytoplasm and nucleus was examined. Intact
nuclei were isolated from fibroblasts grown as monolayer
or in three-dimensional collagen gel. Western analysis was
performed with cytoplasmic and nuclear fractions. While
PKC-m was predominantly present in the cytoplasm, PKC-z
was detected in both cytoplasm and nucleus (Fig. 7). Cells
grown in collagen gel did not change the distribution be-
tween the two subcellular compartments. Therefore, PKC-z,
the kinase required for collagen gel regulatory pathway
leading to a2 and MMP-1 mRNA expression in human
dermal fibroblasts, is constitutively a nuclear as well as a
cytoplasmic protein.
Discussion
We have previously shown that a three-dimensional col-
lagen lattice, either stressed or relaxed, can induce integrin
a2 mRNA expression in human dermal fibroblasts (Xu and
Clark, 1996). Interestingly, no induction of a2 or MMP-1
mRNA is observed when fibroblasts are plated on a col-
lagen monolayer (Fig. 1 A) as previously reported by Lang-
holz et al. (1995) for MMP-1. The evidence presented in
this report indicates that PKC-z is required for the full re-
sponse of integrin a2 subunit and MMP-1 mRNA to col-
lagen lattice (Fig. 6).
Although the nature of precise primary signals triggered
by a three-dimensional type I collagen construct is unde-
fined, we report here that these collagen gels activate
PKC-z (Fig. 4 A) as a component of secondary transduc-
tion signals (second messenger pathway). How might col-
lagen gel activate PKC-z? Previously, we showed that
PDGF can induce PKC-z activity (Xu et al., 1996). Could
collagen gel use the same pathway as PDGF to activate
PKC-z? In fact, adhesion molecules such as CAMs (cell
adhesion molecules) and basic fibroblast growth factor
both activate FGF receptor to induce cell contact–depen-
dent neurite outgrowth (Williams et al., 1994). However,
several lines of evidence argue against the similar scheme
with collagen gel and PDGF. First, Lin and Grinnell (1993)
have presented evidence that PDGF, but not collagen gel,
induces tyrosine phosphorylation of PDGF receptor in fi-
broblasts. Second, the same report also showed that col-
lagen gel, especially relaxed collagen gel, actually reduces
PDGF-stimulated receptor autophosphorylation. Third,
we previously reported that collagen gel does not stimu-
late expression of integrin a3 and a5 subunits, two PDGF-
inducible genes (Xu and Clark, 1996). Fourth, collagen gel
possesses both positive and negative impact on PDGF
stimulation of integrin subunit mRNA expression: positive
on a2, negative on a3 and a5 (Xu and Clark, 1996). The
data taken together, in fact, indicate that collagen gel in-
terferes with some PDGF pathways. Thus, collagen gel
and PDGF signaling pathways appear not to converge at
PDGF receptor site. 
Among known activators of PKC-z are AA generated
by phospholipase A2 and ceramide generated by phos-
phatidylcholine-hydrolyzing phospholipase C (PC-PLC)/
sphingomyelinase. Adhesion of HeLa cells to collagen
(Chun and Jacobson, 1993) or b1 integrin clustering (Auer
and Jacobson, 1995) increased the release of AA. AA
could activate PKC-z either directly (Nakanishi and Ex-
ton, 1992) or indirectly by triggering DAG release (Auer
and Jacobson, 1995). DAG released from AA metabolism
may activate PKC-z by sphingomyelinase-ceramide path-
way since it was able to increase sphigomyelin hydrolysis
in some cell types (Kolesnick, 1987). Alternatively, col-
lagen gel may sequentially activate PC-PLC and PKC-z. In
our system, disruption of PC-PLC activity with its inhibi-
tor D609 (Schutze et al., 1992) blocked collagen gel induc-
tion of a2 mRNA expression (data not shown), implicating
the importance of this pathway. Another possibility for
PKC-z activation by collagen gel may be its phosphoryla-
tion by a second serine/threonine kinase. Several reports
have suggested that the phosphorylation may precede the
PKC activation (Pears et al., 1992; Cazaubon and Parker,
1993). This phosphorylation requirement has been shown
with PKC-a and -b (Cazaubon et al., 1994; Orr and New-
ton, 1994). Potential phosphorylation sites are thought to
be present in several members of PKC family, including z
(Tsutakawa et al., 1995). In agreement with this, the clus-
tering of a2 and b1, the subunits of collagen receptor integrin
a2b1, which was reported to mediate collagen gel–induced
Figure 7. Western analysis of PKC isoforms in cytoplasma and
nuclei. Normal human dermal fibroblasts were starved 1 d in 1%
FCS/DME before subculture in test conditions. Cells were sub-
cultured on tissue culture plates (TC) or in three-dimensional col-
lagen lattices (COL) for 18–24 h. Nuclear (Nuclei) and cytoplas-
mic (Cell Extracts) fractions were prepared, quantified with BCA
assay, blotted, and detected with antibodies against PKC-z and -m.Xu and Clark Integrin and Protease Regulation by Extracellular Matrix 481
MMP-1 expression (Langholz et al., 1995), can induce
p21ras activation (Kapron-Bras et al., 1993). Ras has been
shown to be coprecipitated with PKC-z and to induce PKC-z
activity (Diaz-Meco et al., 1994b). Indeed, our data showed
that collagen gel did not alter the cellular level of PKC-z
(Fig. 3). Thus, posttranslational modification is a possible
mechanism by which PKC-z is regulated. 
The downstream targets of PKC-z activity are yet to be
discovered. One consequence of PKC-z activation by ex-
tracellular stimuli such as TNF-a is the induction of NF-kB
activity (Diaz-Meco et al., 1994a). Here we present evi-
dence from gel mobility shift assays that collagen lattices in-
duced NF-kB DNA binding activity in dermal fibroblasts
rapidly (<30 min) and persistently (>24 h) (Fig. 4 B). This
is in concordance with the observation that cells stimu-
lated with TNF-a and p21Ras demonstrate both increased
PKC-z and NF-kB activities (Diaz-Meco et al., 1994a;
Muller et al., 1995). In fact, TNF-a was also shown to in-
duce NF-kB DNA binding rapidly and persistently (1/3–20 h)
(Johnson et al., 1996; Roff et al., 1996), similar to collagen
gel induction. One puzzling observation was that during a
24-h incubation period, PKC-z kinase activity peaked at 4 h,
whereas NF-kB DNA binding activity reached the maxi-
mum at 24 h with modest increase over the binding at 30
min (Fig. 4 C). While rapid increase of NF-kB activity is
predominantly caused by posttranslational modification
(for review see Siebenlist et al., 1994), sustained nuclear
NF-kB activity over longer periods of stimulation may be
caused by either sustained reduction of NF-kB inhibitor B,
as demonstrated in vascular endothelial cells (Johnson et al.,
1996), or induced expression of NF-kB subunits other than
RelA (p65), as reported for HL60 cells (Hohmann et al.,
1991). Both c-Rel and RelB can be transcriptionally regu-
lated through the kB element in their promoters (Hannink
and Temin, 1990; Ryseck et al., 1992), which p65 lacks
(Ueberla et al., 1993). Stimulation of Jurkat cells over sev-
eral hours results in increasing amounts of c-Rel relative
to p65 in the nucleus, possibly because of preferentially in-
duced levels of c-Rel (Molitor et al., 1990; Doerre et al.,
1993). In support of this, results from supershift assay
showed very low levels of p65 in the kB-binding complex
(Fig. 4 B). We speculate that the rapid binding observed
may be caused by phosphorylation of existing NF-kB/Rel
in cellular pool, whereas the persistent binding may result
from the newly synthesized NF-kB/Rel. Therefore, although
PKC-z reached the maximum at 4 h, NF-kB binding activ-
ity may not show identical kinetics and fold-increases be-
cause of regulatory transition from posttranscriptional
modification of existing protein factors to synthesis and
modification of new proteins. In agreement with this, we
obtained evidence that collagen gel induction of a2 and
MMP-1 mRNA expression, a PKC-z–mediated event, re-
quires both NF-kB (unpublished data) and protein synthe-
sis (Fig. 2 A). 
It is of great interest that collagen gel and PDGF (Xu et al.,
1996) both require PKC-z activity to induce integrin a2
mRNA expression. How is the induction further enhanced
when both signals are present (Fig. 1 C)? Although the
study is at a stage too early to provide answers, there are
several possibilities. First, PKC-z activity has been shown
to be regulated by protein–protein interactions with apop-
tosis gene par-4 product (Diaz-Meco et al., 1996b), l-inter-
acting protein (LIP) (Diaz-Meco et al., 1996a), and Ras
(Diaz-Meco et al., 1994b). Thus, collagen gel and PDGF
might induce different protein factors that in turn activate
PKC-z by protein–protein interaction. Copresence of both
stimuli could synergistically induce the kinase activity by
the interaction among multifactors. Second, there are mul-
tiple potential phosphorylation sites in PKC-z molecules
(Tsutakawa et al., 1995). The fact that PKC-z is physically
interacting with and activated by Ras (Diaz-Meco et al.,
1994b) suggests that phosphorylation is an important
means of regulating its activity. Thus, collagen gel and
PDGF may activate PKC-z by inducing phosphorylation
at different amino acid residue(s). A similar scheme was
suggested in the synergistic activation of NF-kB by cal-
cium and Ras/Raf (for review see Baeuerle and Baltimore,
1996). Third, PKC-z can induce transactivating activities
of different transcription factors such as NF-kB and AP-1
(Bjorkoy et al., 1995). A differentially activated PKC-z
could stimulate distinct downstream pathways. We have
observed that collagen gel stimulated DNA binding activ-
ity of NF-kB (Fig. 4 B) but not AP-1 (unpublished data).
In contrast, PDGF induced DNA binding of substantial
AP-1 but little NF-kB (unpublished data). It is tempting to
suggest that collagen gel/PKC-z and PDGF/PKC-z acti-
vate different transcription factors to induce integrin a2
and MMP-1 mRNA expression. The synergistic action then
would occur at the level of gene transcription. Investiga-
tions of these possibilities are ongoing in our laboratory.
It is well established that three-dimensional collagen
matrix sends integrated physical and chemical signals to
the interior of the cell. Nevertheless, detailed knowledge
of collagen matrix signal transduction is very limited. Re-
sults reported here connect a signal transduction protein,
PKC-z, to the upstream initiator, the collagen lattice, and
to downstream outputs, a2 and MMP-1 mRNA expression.
We thank Dr. Marcia Simon, Department of Dermatology, SUNY at
Stony Brook, NY, for adult human dermal fibroblasts, Dr. Yoshikazu
Takada of The Scripps Institute, La Jolla, CA, for human a2 cDNA probe,
and Charles Hart of ZymoGenetics, Seattle, WA, for PDGF-BB.
Funding for this work was provided by National Institutes of Health
grant AG10114309 to R.A.F. Clark. J. Xu is supported by funding from
the Dermatology Foundation and the School of Medicine, SUNY at Stony
Brook.
Received for publication 30 August 1996 and in revised form 6 November
1996.
References
Ahlen, K., and K. Rubin. 1994. Platelet-derived growth factor-BB stimulates
synthesis of the integrin a2-subunit in human diploid fibroblasts. Exp. Cell
Res. 215:347–353.
Auer, K.L., and B.S. Jacobson. 1995. b1 integrins signal lipid second messen-
gers required during cell adhesion. Mol. Biol. Cell 6:1305–1313.
Baeuerle, P.A. and D. Baltimore. 1996. NF-kB: ten years after. Cell. 87:13–20.
Barbee, J.L., S.L. Deutscher, C.R. Loomis, and D.J. Burns. 1993. The cDNA se-
quence encoding human kinase C-z. Gene. 132:305–306.
Bjorkoy, G., A. Overvatn, M.T. Diaz-Meco, J. Moscat, and T. Jojansen. 1995.
Evidence for a bifurcation of mitogenic signaling pathway activated by Ras
and phosphatidylcholine-hydrolyzing phospholipase C. J. Biol. Chem. 270:
21299–21306.
Cazaubon, S.M., and P.J. Parker. 1993. Identification of the phosphorylated re-
gion responsible for the permissive activation of protein kinase C. J. Biol.
Chem. 268:17559–17563.
Cazaubon, S., F. Bornancin, and P.J. Parker. 1994. Threonine-497 is a critical
site for permissive activation of protein kinase Ca. Biochem. J. 301:443–448.
Chromczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by
acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Bio-The Journal of Cell Biology, Volume 136, 1997 482
chem. 162:156–159.
Chun, J.-S., and B.S. Jacobson. 1992. Spreading of HeLa cells on a collagen sub-
stratum requires a second messenger formed by the lipoxygenase metabo-
lism of arachidonic acid released by collagen receptor clustering. Mol. Biol.
Cell. 3:481–492.
Chun, J.-S., and B.S. Jacobson. 1993. Requirement for diacylglycerol and pro-
tein kinase C in HeLa cell-substratum adhesion and their feedback amplifi-
cation of arachidonic acid production for optimum cell spreading. Mol. Cell.
Biol. 4:271–281.
Chun, J.-S., and B.S. Jacobson. 1996. Differential translocation of protein ki-
nase C-e during HeLa cell adhesion to a gelatin substratum. J. Biol. Chem.
271:13008–13012.
Clark, R.A.F. 1996. Wound repair: overview and general considerations. In
Molecular and Cellular Biology of Wound Repair. 2nd ed. R.A.F. Clark, ed-
itor. Plenum Press, New York. 3–50.
Clark, R.A.F., L.D. Nielsen, M.P. Welch, and J.M. McPherson. 1995. Collagen
matrices attenuate the collagen synthetic response of fibroblasts to TGF-b.
J. Cell Sci. 108:1251–1261.
Diaz-Meco, M.T., E. Berra, M.M. Municio, L. Sanz, J. Lozano, I. Dominguez,
V. Diaz-Golpe, M.T.L. de Lera, J. Alcami, C.V. Paya, et al. 1993. A domi-
nant negative protein kinase C z subspecies blocks NF–kB activation. Mol.
Cell. Biol. 13:4770–4775.
Diaz-Meco, M.T., I. Dominguez, L. Sanz, P. Dent, J. Lozano, M.M. Municio, E.
Berra, R.T. Hay, T.W. Sturgill, and J. Moscat. 1994a. zPKC induces phos-
phorylation and inactivation of IkB-a in vitro. EMBO (Eur. Mol. Biol. Or-
gan.) J. 13:2842–2848.
Diaz-Meco, M.T., J. Lozano, M.M. Municio, E. Berra, S. Frutos, L. Sanz, and J.
Moscat. 1994b. Evidence for the in vitro and in vivo interaction of ras with
protein kinase C. J. Biol. Chem. 269:31706–31710.
Diaz-Meco, M.T., M.M. Municio, P. Sanchez, and J. Lozano. 1996a. l-Interact-
ing protein, a novel protein that specifically interacts with the zinc finger do-
main of the atypical protein kinase C isotype l/t and stimulates its kinase ac-
tivity in vitro and in vivo. Mol. Cell. Biol. 16:105–114.
Diaz-Meco, M.T., M.M. Municio, S. Frutos, P. Sanchez, J. Lozano, L. Sanz, and
J. Moscat. 1996b. The product of par-4, a gene induced during apoptosis, in-
teracts selectively with the atypical isoforms of protein kinase C. Cell. 86:
777–786.
Disatnik, M.H., G. Buraggi, and D. Mochly-Rosen. 1994. Localization of pro-
tein kinase C isozymes in cardiac myocytes. Exp. Cell Res. 210:287–297.
Doerre, S., P. Sista, S.-C. Sun, D.W. Ballard, and W.C. Greene. 1993. The c-rel
protooncogene product represses NF-kB p65-mediated transcriptional acti-
vation of the long terminal repeat of type I human immunodeficiency virus.
Proc. Natl. Acad. Sci. USA. 90:1023–1027.
Eckes, B., C. Mauch, G. Huppe, and T. Krieg. 1993. Downregulation of col-
lagen synthesis in fibroblasts within three-dimensional collagen lattices in-
volves transcriptional and posttranscriptional mechanisms. FEBS Lett. 318:
129–133.
Ferns, G.A.A., E.W. Raines, K.H. Sprugel, A.S. Motani, M.A. Reidy, and R.
Ross. 1991. Inhibition of neoinitimal smooth muscle accumulation after an-
gioplasty by an antibody to PDGF. Science (Wash. DC). 253:1129–1132.
Gimond, C., A. de Melker, M. Aumailley, and A. Sonnenberg. 1995. The cyto-
plasmic domain of a6A integrin subunit is an in vitro substrate for protein
kinase C. Exp. Cell Res. 216:232–235.
Greenberg, M.E., and E.B. Ziff. 1984. Stimulation of 3T3 cells induces tran-
scription of the c-fos proto-oncogene. Nature (Lond.). 311:433–438.
Grinnell, F. 1994. Fibroblasts, myofibroblasts, and wound contraction. J. Cell
Biol. 124:401–404.
Hagiwara, M., C. Uchida, N. Usuda, T. Nagata, and H. Hidaka. 1990. z-Related
protein kinase C in nuclei of nerve cells. Biochem. Biophys. Res. Commun.
168:161–168.
Hannink, M., and H.M. Temin. 1990. Structure and autoregulation of the c-rel
promoter. Oncogene. 5:1843–1850.
Hay, E.D. 1991. Collagen and other matrix glycoproteins in embryogenesis.
Cell Biology of the Extracellular Matrix. E.D. Hay, editor. Plenum Press,
New York. 419–462.
Hohmann, H.-P., R. Remy, C. Scheidereit, and A.P.G.M. vanLoon. 1991. Main-
tenance of NF-kB activity is dependent on protein synthesis and the continu-
ous presence of external stimuli. Mol. Cell. Biol. 11:259–266.
Johnson, D.R., I. Douglas, A. Jahnke, S. Ghosh, and J.S. Pober. 1996. A sus-
tained reduction in IkB-b may contribute to persistent NF-kB activation in
human endothelial cells. J. Biol. Chem. 271:16317–16322.
Kapron-Bras, C., L. Fitz-Gibbon, P. Jeevaratnam, J. Wilkins, and S. Dedhar.
1993. Stimulation of tyrosine phosphorylation and accumulation of GTP-
bound p21ras upon antibody-mediated a2b1 integrin activation in T-lym-
phoblastic cells. J. Biol. Chem. 268:20701–20704.
Klein, C.E., D. Dressel, T. Steinmayer, C. Mauch, B. Eckes, T. Krieg, R.B.
Bankert, and L. Weber. 1991. Integrin a2b1 is upregulated in fibroblasts and
highly aggressive melanoma cells in three-dimensional collagen lattices and
mediates the reorganization of collagen I fibrils. J. Cell Biol. 115:1427–1436.
Kolesnick, R.N. 1987. 1,2-Diacylglycerols but not phorbol ester stimulate sphin-
gomyelin hydrolysis in GH3 pituitary cells. J. Biol. Chem. 262:16759–16762.
Langholz, O., D. Rockel, C. Mauch, E. Kozlowska, I. Bank, and T. Krieg. 1995.
Collagen and collagenase gene expression in three-dimensional collagen lat-
tices are differentially regulated by a1b1 and a2b1 integrins. J. Cell Biol.
131:1903–1915.
Larivee, P., S.J. Levine, A. Martinez, T. Wu, C. Logun, and J.H. Shelhamer.
1994. Platelet-activating factor induces airway mucin release via activation
of protein kinase C: evidence for translocation of protein kinase C to mem-
branes. Am. J. Respir. Cell Mol. Biol. 11:199–205.
Larrodera, P., M.E. Cornet, M.T. Diaz-Meco, M. Lopez-barahona, I. Diaz-
Laviada, P.H. Guddal, T. Johansen, and J. Moscat. 1990. Phospholipase
C-mediated hydrolysis of phosphatidylcholine is an important step in
PDGF-stimulated DNA synthesis. Cell. 61:1113–1120.
Li, J., Z. Zhu, and Z. Bao. 1996. Role of MacMARCKS in integrin-dependent
macrophage spreading and tyrosine phosphorylation of paxillin. J. Biol.
Chem. 271:12985–12990.
Lin, C.Q., and M.J. Bissell. 1993. Multi-faceted regulation of cell differentiation
by extracellular matrix. FASEB J. 7:737–743.
Lin, Y.-C., and F. Grinnell. 1993. Decreased level of PDGF-stimulated receptor
autophosphorylation by fibroblasts in mechanically relaxed collagen matri-
ces. J. Cell Biol. 122:663–672.
Lozano, J., E. Berra, M.M. Municio, M.T. Diaz-Meco, I. Dominguez, L. Sanz,
and J. Moscat. 1994. Protein kinase C z isoform is critical for kB-dependent
promoter activation by sphingomyelinase. J. Biol. Chem. 269:19200–19202.
Masmoudi, A., G. Labourdette, M. Marsel, F.L. Huang, K.-P. Huang, G. Vin-
cendon, and A.N. Malviya. 1989. Protein kinase C located in rat liver nuclei:
partial purification and biochemical and immunochemical characterization.
J. Biol. Chem. 264:1172–1179.
Molitor, J.A., W.H. Walker, S. Doerre, D.W. Ballard, and W.C. Greene. 1990.
NF-kB: a family of inducible and differentially expressed enhancer-binding
proteins in human T cells. Proc. Natl. Acad. Sci. USA. 87:10028–10032.
Muller, G., M. Ayoub, P. Storz, J. Rennecke, D. Fabbro, and K. Pfizenmaier.
1995. PKC-z is a molecular switch in signal transduction of TNF-a, bifunc-
tionally regulated by ceramide and arachidonic acid. EMBO (Eur. Mol. Biol.
Organ.) J. 14:1961–1969.
Nakanishi, H., and J.H. Exton. 1992. Purification and characterization of the z
isoform of protein kinase C from bovine kidney. J. Biol. Chem. 268:13–16.
Nakanishi, H., K.A. Brewer, and J.H. Exton. 1993. Activation of the z isoform
of protein kinase C by phosphatidylinositol 3,4,5-triphosphate. J. Biol.
Chem. 268:13–16.
Nishizuka, Y. 1992. Intracellular signalling by hydrolysis of phospholipids and
activation of protein kinase C. Science (Wash. DC). 258:607–614.
Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular
responses. FASEB J. 9:484–496.
Orr, J.W., and A.C. Newton. 1994. Requirement for negative charge on “activa-
tion loop” of protein kinase C. J. Biol. Chem. 269:27715–27718.
Pears, C., S. Stabel, S. Cazaubon, and P.J. Parker. 1992. Studies on the phos-
phorylation of protein kinase C-a. Biochem. J. 283:515–518.
Pinol-Roma, S., and G. Dreyfuss. 1992. Shuttling of pre-mRNA binding pro-
teins between nucleus and cytoplasm. Nature (Lond.). 355:730–732.
Roff, M., J. Thompson, M.S. Rodriguez, J.-M. Jacque, F. Baleux, F. Arenzana-
Seisdedos, and R.T. Hay. 1996. Role of IkBa ubiquitination in signal-
induced activation of NF-kB in vivo. J. Biol. Chem. 271:7844–7850.
Ronnov-Jessen, L., O.W. Petersen, V.E. Koteliansky, and M.J. Bissell. 1995.
The origin of the myofibroblasts in breast cancer. Recapitulation of tumor
environment in culture unravels diversity and implicates converted fibro-
blasts and recruited smooth muscle cells. J. Clin. Invest. 96:859–873.
Rosenberger, U., M. Shakibaei, and K. Buchner. 1995. Localization of non-con-
ventional protein kinase C isoforms in bovine brain cell nuclei. Biochem. J.
305:269–275.
Ryseck, R.P., P. Bull, M. Takamiya, V. Bours, and U. Siebenlist. 1992. RelB, a
new rel family transcription activator that can interact with p50-NF-kB. Mol.
Cell. Biol. 12:674–684.
Sankar, S., N. Mahooti-Brooks, L. Bensen, T.L. McCarthy, M. Centrella, and
J.A. Madri. 1996. Modulation of transforming growth factor b receptor lev-
els on microvascular endothelial cells during in vitro angiogenesis. J. Clin.
Invest. 97:1436–1446.
Schreiber, E., P. Matthias, M.M. Muller, and W. Schaffner. 1989. Rapid detec-
tion of octamer binding proteins with ‘mini-extracts’ prepared from a small
number of cells. Nucleic Acids Res. 17:6419–6420.
Schutze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Kronke.
1992. TNF activates NF-kB by phosphatidylcholine-specific phospholipase
C-induced “acidic” sphingomyelin breakdown. Cell. 71:765–776.
Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation, and
function of NF-kB. Annu. Rev. Cell Biol. 10:405–455.
Streuli, C.H., C. Schmidhauser, N. Bailey, P. Yurchenco, A.P.N. Skubitz, C.
Roskelley, and M.J. Bissel. 1995. Laminin mediates tissue-specific gene ex-
pression in mammary epithelia. J. Cell Biol. 129:591–603.
Takada, Y., and M.E. Hemler. 1989. The primary structure of the VLA-2/col-
lagen receptor a2 subunit (platelet GPIa): homology to other integrins and
the presence of a possible collagen-binding domain. J. Cell Biol. 109:397–407.
Tang, J.Y., J. Temsamani, and S. Agrawal. 1993. Self-stabilized antisense oli-
godeoxynucleotide phosphorothioates: properties and anti-HIV activity.
Nucleic Acids Res. 21:2729–2735.
Thompson, L., and A.P. Fields. 1996. bII protein kinase C is required for the
G2/M phase transition of cell cycle. J. Biol. Chem. 271:15045–15053.
Tsutakawa, S.E., K.F. Medzihradszky, A.J. Flint, A.L. Burlingame, and J.D.E.
Koshland. 1995. Determination of in vivo phosphorylation sites in protein
kinase C. J. Biol. Chem. 270:26807–26812.
Ueberla, K., Y.C. Lu, E. Chung, and W.A. Haseltine. 1993. The NF-kB p65 pro-Xu and Clark Integrin and Protease Regulation by Extracellular Matrix 483
moter. J. AIDS Res. 6:227–230.
Unemori, E.N., and Z. Werb. 1986. Reorganization of polymerized actin: a pos-
sible trigger for induction of procollagenase in fibroblasts cultured in and on
collagen gels. J. Cell Biol. 103:1021–1031.
Ventura, C., G. Pintus, I. Vaona, F. Bennardini, G. Pinna, and B. Tadolini.
1995. Phorbol ester regulation of opioid peptide gene expression in myocar-
dial cells: role of nuclear protein kinase C. J. Biol. Chem. 270:30115–30120.
Vuori, K., and E. Ruoslahti. 1993. Activation of protein kinase C precedes a5b1
integrin-mediated cell spreading on fibronectin. J. Biol. Chem. 268:21459–
21462.
Williams, E.J., J. Furness, F.S. Walsh, and P. Doherty. 1994. Activation of the
FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM, and
N-cadherin. Neuron. 13:583–594.
Woods, A., and J.R. Couchman. 1992. Protein kinase C involvement in focal
adhesion formation. J. Cell Sci. 101:277–290.
Wooten, M.W., G. Zhou, M.L. Seibenhener, and E.S. Coleman. 1994. A role
for z protein kinase C in nerve growth factor-induced differentiation of PC12
cells. Cell Growth Differ. 5:395–403.
Xu, J., and R.A. Clark. 1996. Extracellular matrix proteins modulate PDGF
regulation of fibroblast integrins. J. Cell Biol. 132:239–249.
Xu, J., M.M. Zutter, S.A. Santoro, and R.A.F. Clark. 1996. PDGF induction of
a2 integrin gene expression is mediated by protein kinase C-z. J. Cell Biol.
134:1301–1311.